25/10/2023
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
October 2023
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Nov »
25/10/2023
Oct 25, 2023, 18:13 |
Blog
Aradhana Sarin: Science + Finance = Innovation
Quoting Aradhana Sarin, Group CFO and Executive Director of AstraZeneca, on LinkedIn: ''Science + Finance =…
Oct 25, 2023, 18:09 |
Blog
Joanna Dodkins: Very excited to be presenting work conducted at the National Prostate Cancer Audit
Joanna Dodkins, Clinical oncology registrar at Guy's Hospital, London, shared on her Twitter: "Very excited to…
Oct 25, 2023, 18:04 |
Insight
Talha Badar: Moving immunotherapy upfront in B-cell ALL
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on Twitter:…
Oct 25, 2023, 17:57 |
Insight
Tian Zhang: Discussed by Sandhu Shahneen — we should likely wait for PSA recurrence before salvage radiation
Tian Zhang recently shared on Twitter: "RADICALS-HD showed a definitive equivalence in survival for adjuvant…
Oct 25, 2023, 17:52 |
Insight
Ilya Tsimafeyeu: Patients with metastatic renal cell carcinoma and high fibrinogen levels who received nivolumab had worse overall survival
Ilya Tsimafeyeu, Director at Bureau of Cancer Research Russia, shared on Facebook: "Our study: Patients…
Oct 25, 2023, 17:44 |
Drugs
Nicolas Hubacz: Top Selling Pharmaceuticals of 2023
Nicolas Hubacz shared on LinkedIn: "Top Selling Pharmaceuticals of 2023. As the COVID-19 pandemic's grip…
Oct 25, 2023, 17:36 |
Blog
Naveen Pemmaraju: Shout out to my fellow co-founding moderators for the successful first-in-person MPN Co&D meeting in Paris.
Naveen Pemmaraju shared on Twitter: "Shout out to my fellow co-founding moderators for the successful…
Oct 25, 2023, 17:30 |
Blog
Russell Conley: I’m so pleased to be back working at the GI Cancer Institute following my cancer treatment
Russell Conley, Chief Executive Officer at GI Cancer Institute, shared on LinkedIn: "I’m so pleased…
Oct 25, 2023, 17:27 |
Insight
Tom Powles: TAR-210 releases Erdafitinib slowly into the bladder by a novel release system
Tom Powles, Director of Barts Cancer Centre, shared on Twitter: ''Something NEW. TAR-210 releases Erdafitinib…
Oct 25, 2023, 17:23 |
Insight
Ishwaria Subbiah: If life’s in the journey and not the endpoint, then preparing our patients and caregivers for the EVP journey is the top priority!
Ishwaria Subbiah shared on Twitter: "Wow! That OS w EVP! This wait for approval is…
1
2
All:
20
Posts:
11 - 20
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube